🇺🇸 FDA
Pipeline program

Standard of Care medication for early Alzheimer's Disease

Telerehab AD Feasibility

Unknown small_molecule active

Quick answer

Standard of Care medication for early Alzheimer's Disease for Alzheimer Disease is a Unknown program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Alzheimer Disease
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials